Author: Yan Li; Jinyong Zhang; Ning Wang; Haibo Li; Yun Shi; Gang Guo; Kaiyun Liu; Hao Zeng; Quanming Zou
Title: Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening Document date: 2020_1_29
ID: iu2ziccm_39
Snippet: Among the four molecules identified in this study, Prulifloxacin is a chemotherapeutic fluoroquinolone antibiotic with broad-spectrum activity, it has been approved for the treatment of uncomplicated and complicated urinary tract infections, community-acquired respiratory tract infections in Italy and gastroenteritis, including infectious diarrheas, in Japan [10] . Unfortunately, Prulifloxacin is reported as a prodrug, which is rapidly metabolize.....
Document: Among the four molecules identified in this study, Prulifloxacin is a chemotherapeutic fluoroquinolone antibiotic with broad-spectrum activity, it has been approved for the treatment of uncomplicated and complicated urinary tract infections, community-acquired respiratory tract infections in Italy and gastroenteritis, including infectious diarrheas, in Japan [10] . Unfortunately, Prulifloxacin is reported as a prodrug, which is rapidly metabolized to ulifloxacin in vivo [11] . But it can be used as a lead compound that provide guidance for our later structural modification and optimization to design more effective main protease inhibitors. Tegobuvir is a novel author/funder. All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- broad spectrum activity and main protease inhibitor: 1
- broad spectrum activity and protease inhibitor: 1, 2, 3, 4, 5
- broad spectrum and guidance provide: 1, 2, 3, 4, 5
- broad spectrum and infectious diarrhea: 1
- broad spectrum and lead compound: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- broad spectrum and main protease inhibitor: 1, 2, 3
- broad spectrum and permission allow: 1
- broad spectrum and protease inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective main protease inhibitor and main protease inhibitor: 1, 2
- effective main protease inhibitor and protease inhibitor: 1, 2
- lead compound and main protease inhibitor: 1
- lead compound and protease inhibitor: 1, 2, 3, 4, 5, 6
- main protease inhibitor and protease inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date